182 related articles for article (PubMed ID: 15266995)
1. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
[TBL] [Abstract][Full Text] [Related]
2. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
3. Risperidone and NMS?
Murray S; Haller E
Psychiatr Serv; 1995 Sep; 46(9):951. PubMed ID: 7583513
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome with risperidone.
Levin GM; Lazowick AL; Powell HS
J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
[No Abstract] [Full Text] [Related]
5. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M
Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104
[TBL] [Abstract][Full Text] [Related]
6. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
10. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
Hasan S; Buckley P
Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
[TBL] [Abstract][Full Text] [Related]
11. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
[TBL] [Abstract][Full Text] [Related]
12. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
Teng PR; Lane HY
J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
[No Abstract] [Full Text] [Related]
13. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
Robb AS; Chang W; Lee HK; Cook MS
J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome in users of risperidone].
Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
16. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
18. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
19. Novel antipsychotics and neuroleptic malignant syndrome.
Buckley P
Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
[No Abstract] [Full Text] [Related]
20. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
